Takasago, Japan

Hiroshi Yamamura

This inventor holds 1 USPTO granted patent. Top assignee: Kanegafuchi Kagaku Kogyo Kabushiki Kaisha. Active years: 1986.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1986

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hiroshi Yamamura: Innovator in Optically Active Compounds

Introduction

Hiroshi Yamamura is a notable inventor based in Takasago, Japan. He has made significant contributions to the field of chemistry, particularly in the production of optically active compounds. His work has implications for the development of pharmaceuticals, especially in the area of beta-adrenergic blocking agents.

Latest Patents

Yamamura holds a patent for a process for the production of optically active oxazolidinone derivatives. This innovative process utilizes microorganisms or enzymes with stereoselective esterase activity to asymmetrically hydrolyze racemates of acyloxyoxazolidinone derivatives. The method involves separating unreacted compounds from hydrolyzed compounds, ultimately leading to the production of useful intermediates for pharmaceutical applications. He has 1 patent to his name.

Career Highlights

Hiroshi Yamamura is associated with Kanegafuchi Kagaku Kogyo Kabushiki Kaisha, where he has been instrumental in advancing research and development in his field. His expertise in optically active compounds has positioned him as a key figure in the company.

Collaborations

Yamamura has collaborated with notable colleagues such as Shigeki Hamaguchi and Junzo Hasegawa. Their combined efforts have contributed to the advancement of innovative processes in the production of pharmaceutical compounds.

Conclusion

Hiroshi Yamamura's work in the field of optically active compounds showcases his innovative spirit and dedication to advancing pharmaceutical science. His contributions continue to influence the development of important medical agents.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…